Steven Pieri

Vice President, Head Of Market Access at Swedish Orphan Biovitrum

Steven Pieri has a diverse work experience spanning over 20 years. Steven is currently the Vice President, Head of Market Access at Sobi - Swedish Orphan Biovitrum AB (publ) since August 2023. Prior to that, they were the Vice President Pricing, Contracting, Trade, and Gov't at Bristol Myers Squibb from April 2020 to August 2023. Steven also worked at Janssen Inc. as the Head of Pricing for various therapeutic areas from February 2019 to April 2020. Before that, they held several roles at Amgen, including Executive Director Reimbursement, Value, and Access from July 2017 to February 2019. Steven also worked as the Director of Repatha Reimbursement Access and Value from May 2013 to June 2017. Steven started their career at King Pharmaceuticals as a Medical Sales Representative in July 2001 and held various positions, including Director of Marketing for Glumetza, Sr. Manager of Sales Planning and Analytics, and District Sales Manager. Steven worked at King Pharmaceuticals until October 2007. Prior to that, they worked at Daiichi Sankyo, Inc. as a Sr. Manager of Market Access from June 2009 to May 2013 and at Wolters Kluwer Health (Symphony Healthcare) as a Sr. Consultant from October 2007 to June 2009.

Steven Pieri earned a Bachelor's degree in Sociology from Saint Joseph's University in 1998. Steven later pursued a Master of Business Administration (MBA) at the same university from 2009 to 2011.

Links

Previous companies

Daiichi Sankyo logo
Amgen logo
Bristol-Myers Squibb logo

Org chart